Fostering Connections and Collaborations With AI Grand Rounds

The Windreich Department of Artificial Intelligence and Human Health at Mount Sinai hosts a monthly AI Grand Rounds, which serves as a forum for clinicians and researchers to share their findings. The October 2025 session featured Vera Sorin, MD, Cardiothoracic Imaging Fellow at the Mayo Clinic as a speaker.

To foster better awareness and collaboration of AI efforts, the Windreich Department of Artificial Intelligence and Human Health (AIHH) at Mount Sinai established its monthly Grand Rounds—sessions for faculty, trainees, and staff to share ideas, learn about cutting-edge developments, and explore how AI and data science are transforming research and clinical care.

“The Grand Rounds series reflects our ongoing commitment to fostering dialogue, intellectual curiosity, and innovation at the intersection of technology and human health,” said Girish N. Nadkarni, MD, MPH, CPH, Chair of AIHH.

Modeled after medical Grand Rounds—but adapted to the unique focus of AI—the series provides a venue where clinicians, data scientists, and researchers can come together to discuss challenges, share insights, and identify opportunities for synergy.

Each Grand Rounds features invited speakers who are recognized leaders in their fields—both within Mount Sinai and from the broader AI and biomedical research communities. Presentations may cover topics such as machine learning applications in health care, ethical AI, biomedical informatics, and translational data science.

The AI Grand Rounds invites speakers who are recognized leaders in their fields, both from within Mount Sinai and externally. In Dr. Sorin’s presentation, she talked about post-deployment AI monitoring in health care radiology, challenges with foundation models, and innovative ways to overcome them.

The inaugural session kicked off in September, with Anthony Costa, PhD, Director of Digital Biology at Nvidia, as its featured speaker, who presented about accelerating the representation of biology and human health with artificial intelligence. The October session’s featured speaker, Vera Sorin, MD, Cardiothoracic Imaging Fellow at the Mayo Clinic, presented on post-deployment AI monitoring in health care radiology, discussing both technical and performance monitoring approaches at Mayo and addressing challenges with foundation models.

The schedule for 2026 is currently being confirmed, with AIHH leadership planning on balancing internal and external voices for the sessions.

Beyond highlighting excellence in research, organizers hope the AIHH Grand Rounds can inspire new methodologies, help participants explore interdisciplinary research ideas, and build meaningful professional connections, said Dr. Nadkarni.

“These sessions are designed to spark new collaborations, inspire cross-departmental initiatives, and deepen our shared understanding of how artificial intelligence can advance human health,” said Dr. Nadkarni. “Over time, we hope the Grand Rounds will serve not only as a learning platform but also as a catalyst for innovation that drives the Department’s research and clinical missions forward.”

A Journey of Firsts at the White Coat Ceremony

For the class of 2029 of the Icahn School of Medicine at Mount Sinai, the White Coat Ceremony marked the start of their medical careers. It was also an opportunity for Mount Sinai staff and faculty to pass on their wisdom about what it means to be on that path.

“As students, it represents the privilege you have earned to study medicine,” said Eric J. Nestler, MD, PhD, Interim Dean of the Icahn School, speaking to the crowd at Alice Tully Hall at Lincoln Center on Tuesday, September 16. “As practitioners, it will be a constant reminder of your sacred responsibility to patients. And to your patients, it will symbolize the deep trust that they place in you,” he said.

Incidentally, remarked Dr. Nestler, just as the event was the first White Coat Ceremony for the incoming class, it was also the first that he had presided over as Interim Dean since assuming the role last year. The incoming class is a diverse group from different socioeconomic, ethnic, and religious backgrounds, with representation from 31 states, 52 different schools, and two who joined from the military. Collectively, class members speak more than 20 different languages.

The new students are stepping into a world that will contain many firsts for diagnosing and treating patients, led by artificial intelligence and genomic sciences, and Dr. Nestler said it will be a world unrecognizable to himself, his peers, and his mentors: “You are preparing to join our profession as it faces a revolutionary inflection point.”

But behind the prestige and brilliance, doctors must remember that they, too, are human, said Brendan G. Carr, MD, MA, MS, Chief Executive Officer and Kenneth L. Davis, MD, Distinguished Chair of the Mount Sinai Health System.

“The point is that medicine will take a toll. And we used to celebrate that. But we don’t anymore,” said Dr. Carr. “We don’t want the numb version of you. We want the version of you that feels deeply and sees the connection you have with your patients. And we want the professional version that commands authority and respect and is polished and professional.”

Class of 2029, By the Numbers

128

Class size

7,529

Number of traditional entry applications

54%

Percentage of women

18

First-generation college students

519

Median MCAT score of class

3.94

Median GPA of class

The class of 2029 is entering medicine with a vision for shaping the future. Click on each student’s name to learn more about why they chose to enter the field and the impact they hope to achieve.

Jude Barakat, Class of 2029

Why did you choose to enter medicine?

I chose to enter medicine after seeing my mom battle her diagnosis with her rare autoimmune disorder, scleroderma. With such a complicated diagnosis, we visited tons of physicians and physician-scientists, where I saw first-hand the impact of their discoveries. Over years, these professionals gave me the invaluable gift of long hikes with my mom and celebrating life milestones—like this White Coat Ceremony—by her side. I hope to do the same for others through my pursuit of science and medicine.

What do you see as gaps that exist in medicine, and how do you think you can help bridge that gap?

I observe a disconnect between scientific research and clinical practice. It’s not only important to pursue our scientific curiosity, but to ground that research and inquiry in advancing care for our patients. In pursuit of my physician-scientist training, I hope to help bridge the gap, speaking both a scientific and medical language to improve human health for my patients and on a larger scale.

What drew you to the Icahn School of Medicine?

As an MD/PhD student, I appreciated that the “bench-to-bedside” translational research model is baked into the very nature of Mount Sinai as both a hospital system and a powerhouse in biomedical research. Beyond the lab, I instantly felt the supportive and collaborative atmosphere from the students and faculty the moment I entered Second Look, the event for accepted students to learn more about the program. Plus, Mount Sinai has the best location of any medical school in the world: next to Central Park and a train ride away from any action of New York.

Interesting facts about yourself?

When not doing science or medicine, I love to watch reality TV—specifically Survivor; I even minored in psychology to study social behavior and dynamics. A life goal of mine is to be on Survivor… maybe during grad school?

 

I am a medical student and so much more. I’m also… an educator and mentor.

Cesar Espinal, Class of 2029

Why did you choose to enter medicine?

I chose to enter medicine because this field will allow me to have an impact on someone’s life during their most vulnerable moments. Having seen how my own life and the lives of my loved ones have benefited through the efforts of compassionate health care workers, I feel both a deep desire and responsibility to provide that same care for others. Whether it’s through a clinical intervention or just being there to listen, I know that my actions as a physician will have the potential to be life-changing. The white coat bestowed upon me symbolizes not just knowledge, but a commitment to consistently honor the privilege of being relied upon to do what is best for my future patients. With every step I take toward honoring that trust, I find myself living out the very reasons I chose this path.

What do you see as gaps that exist in medicine, and how do you think you can help bridge that gap?

A major gap I see in medicine is the lack of adequate language access for patients with limited English proficiency. Through my experience researching language access in New York City public hospitals, I have become aware of the fact that patients who don’t share a common language with their care team often struggle to fully understand their care, and relying on telephonic or video interpreters can make it even harder to feel truly connected and comfortable.

Now, as a medical student, I am grateful to take a more active part in addressing them as a Spanish interpreter at the East Harlem Health Outreach Partnership, where I hope to serve as both a language and cultural bridge between patients and providers. Through work like this, I hope to grow into a physician who not only recognizes these invisible barriers but also becomes more mindful of how to better connect with patients whose languages I do not speak.

What drew you to the Icahn School of Medicine?

I was initially drawn to the Icahn School of Medicine because of the FlexMed program, which allowed me to live in Spain and Argentina to strengthen my fluency in Spanish—it’s my heritage language that I didn’t grow up speaking, even though my mum is from Mexico, and my dad is from the Dominican Republic. During those years, I also conducted research at NYU Langone, Bellevue Hospital, and the Columbia University Mailman School of Public Health, examining language access and minority health in hospitals serving largely Hispanic communities across New York City.

Now, I hope to bring these skills and experiences back to East Harlem by serving the vast Hispanic patient population that comes to Mount Sinai for care. Access to such a community has always been central to where I envision practicing medicine, as I strive to bridge language gaps for the community I come from but could not always fully connect with. Achieving this dream has only been possible because of the Icahn School of Medicine, which gave me the foundation I needed to serve this community today.

Interesting facts about yourself?

I’ve traveled to five continents and I’ve lived in four. But more impressively, I can solve a Rubik’s cube in 17 seconds.

 

I am a medical student and so much more. I’m also… a runner, a cyclist, and hopefully a future triathlete.

Eva Ingber, Class of 2029

Why did you choose to enter medicine?

I was an avid reader as a teen, deeply stirred by the works I read, such that I often thought to myself: I want to do this. At the time, I thought “this” meant that I strictly wanted to be a writer, a storyteller. Over time, I learned what it was that truly inspired me: I wanted to touch people’s lives the way books touched mine. Over time, this same feeling—coupled with an ever-growing interest in science, a craving for interpersonal connection, and a firm belief that actions often speak louder than words—led me to the realization that I didn’t just want to write people’s stories, I wanted to take an active part in shaping them. This desire was cemented the summer before my senior year of high school, when I had my first shadowing experience. I witnessed a J–pouch procedure, and the surgeon had me hold the freshly removed colon.

I often think back to that moment, to the emotions I felt all at once: disbelief that I was holding a part of the human body, deep sadness for the patient who just lost an organ and whose life would be forever changed, but also reverence for the ingenuity of medicine. I have been privileged to witness cutting-edge procedures, but my reverence of medicine is equally attributable to the littlest moments I’ve seen: a resident holding a hysterectomy patient’s hand as she awoke from surgery, a physician delicately fixing the gown of an anesthetized patient for privacy, an entire operating room of staff singing Bob Marley’s “Three Little Birds” for a patient as she drifted to sleep. The stimulation and connection I’ve sought on the page are everywhere in the hospital. I am inspired and deeply moved by the humanness of medicine, a field that is a constant reminder of the paradoxical duality of our existence: we are flesh and bone, and we possess such awesome potential.

What do you see as gaps that exist in medicine, and how do you think you can help bridge that gap?

I have observed—both in the clinical space, amongst my peers, and during my own experiences as a patient—the helplessness that can arise in the moments after leaving a physician’s care. A patient can be given instructions but face frustrating and confusing obstacles in trying to complete them. I feel that the onus of navigating these next logistical steps should not fall squarely on a patient’s shoulders. The logistic and circumstantial barriers to care can be mitigated by more physicians not only telling patients what their next steps should be, but how they can accomplish them.

This clarity might be as simple as affirming for a patient that their office will handle filling the prescription or that they will take care of reaching out to pathology to receive the necessary slides. I hope that every patient I am privileged to treat not only feels cared for in my presence, but leaves with this same feeling, empowered and confident in their understanding of their health and how to continue protecting it.

What drew you to the Icahn School of Medicine?

As a volunteer researcher at Mount Sinai during my undergraduate years, I would walk into the Annenberg Building and be surrounded by the vibrancy of Mount Sinai—doctors and nurses in scrubs running to grab lunch between shifts, families coming to visit loved ones, researchers carrying samples on ice, cleaning staff making sure that the hospital shines, and delivery people bringing essential goods to their respective locations.

I’ve seen firsthand the unique paradox of the Mount Sinai community: that despite its large size, its magnitude of accomplishments, Mount Sinai has created and cultivated warmth and intimacy across the institution in a way that is palpable. From the new ASCEND curriculum that breathes life into the facts and goes beyond lecture learning, to the cutting-edge research and clinical opportunities that come from the immersiveness of a medical school that’s part of a hospital, to the equitable model of care and emphasis on the dynamic role of physicians, I am inspired by the way the Icahn School of Medicine teaches and practices the art of medicine. I wanted to attend a medical school that, like me, believes care goes beyond a diagnosis—and I know with absolute certainty that Mount Sinai is that school.

Interesting facts about yourself?

I was in a rock band growing up. I was the lead singer!

 

I am a medical student and so much more. I’m also… daughter, sister, granddaughter, wife, writer, reader, artist, lover of music (anything from Frank Sinatra to Taylor Swift), and an exercise aficionado.

Rahmah Jingo, Class of 2029

Why did you choose to enter medicine?

I have felt a calling to medicine for as long as I can remember. My dad is an internist, and as a kid, my favorite days were going with him to work. I loved seeing my dad share the understanding and caring side of himself that I loved so much with his patients. This was my earliest insight into how special the physician-patient relationship truly is. I grew older and pursued patient-facing experience by volunteering as an EMT and working at an urgent care facility. I learned to anticipate and respond to my patients’ needs, and I built meaningful relationships grounded in compassion and trust during moments of vulnerability. My work gave me the clarity to recognize my purpose: to pursue the clinical training and scientific knowledge that would best equip me to meet others’ health needs. I chose medicine knowing it is a privilege to wake up every day with the opportunity to make a meaningful difference in the lives of others.

What do you see as gaps that exist in medicine, and how do you think you can help bridge that gap?

There are an overwhelming number of issues that come to mind. Limitations exist in structural barriers to care, workforce burnout, policy changes, health care costs—to name a few. In pursuing a medical career, I have considered the way being a physician would put me in a unique position for advocacy that leads to widespread policy changes. I’ve seen how practicing medicine informs research that uncovers clinically relevant solutions to address such gaps. However, I am but one individual, still uncovering where medicine will ultimately take me. At this stage, I know the most important thing I can do is hold hope for a better future. Hope allows us to imagine what a better future looks like, and from that imagination, tangible and necessary action may arise.

What drew you to the Icahn School of Medicine?

I attended a medical conference early in my undergraduate career when I first met students from the Icahn School of Medicine. It was very easy to see myself attending this school; I saw a bit of myself in the students I met. I made sure to ask the “hard” questions about life as a medical student, and left with the feeling that I would be well-supported and welcomed by this institution. I got the sense that the values the Icahn School upholds aligned extremely well with my own. I wanted to be in a school that centers the patients, the greater community around us, and the pursuit of science. All of those factors gave me confidence that I would fully step into my potential as a doctor by attending the Icahn School.

Interesting facts about yourself?

For middle and high school, I went to international schools in my hometown, Atlanta, Georgia, and in Kampala, Uganda. Because of that, I have made lifelong friends from many different places around the world.

 

I am a medical student and so much more. I’m also… a daughter, a sister, and a friend. I’m also a person who commits herself to too many hobbies!

Beyond the Scalpel, Learning About Humanities in Medicine

From left to right: Alexis Hatch, MD student and organizer of the Two-Minute Talks in the Medical Humanities; Suzanne Garfinkle, MD, Director, Academy for Medicine and the Humanities; and Jacob Appel, MD, JD, MPH, Assistant Director, Academy for Medicine and the Humanities.

Training to be a researcher or physician at the Icahn School of Medicine at Mount Sinai isn’t just about excellence at the bench and bedside but also understanding the humanity that underpins these callings.

Thus exists the field of “medical humanities,” an area of study that draws upon the arts, the humanities, and the social sciences to enhance medical practice. On Thursday, September 18, members from the Mount Sinai Health System were invited to share and learn about topics where humanities and medicine intersect at the inaugural Two-Minute Talks in Medical Humanities.

With just 120 seconds each, 18 presenters—spanning faculty members, medical students, master’s students, and PhD students—covered topics they were passionate about: Where did Leonardo da Vinci think the soul was located in the body? How has the medical stretcher evolved through time? Can listening to Indian classical music have therapeutic effects?

“As a student admitted through Flex Med, a program designed to bring students in the humanities into medicine, I know firsthand how valuable a humanities background is when learning how to be a compassionate physician,” said Alexis Hatch, a second-year MD student, who came up with the idea for the event.

The inspiration for Two-Minute Talks came from Ms. Hatch’s time as an undergraduate at the University of Chicago, where she participated in a similar event. “When I started as a student ambassador for the Academy for Medicine and the Humanities at the Icahn School of Medicine, I immediately thought a similar event would draw students and faculty to share their interests outside of clinical medicine or research,” she said. “I knew the interest was there—every time I shadowed a physician, they seemed much more interested in discussing my history degree than any scientific research I did!”

“We loved the idea because you can teach an audience a great deal in two minutes, and the time limit made each talk extra dynamic,” said Suzanne Garfinkle, MD, Founding Director of the Academy, and Assistant Clinical Professor of Medical Education. “The event offered a very special window into participants’ creative and scholarly passions. I could see these two-minute lectures developing into a real Mount Sinai tradition.”

Take a look at what some of the presenters talked about during the event in the slideshow below.

Alexis Hatch, medical student and organizer of the Two-Minute Talks in Medical Humanities, gave a presentation on things that exist today thanks to the existence of tuberculosis.
In addition to tuberculosis camp towns—the roots of places like Colorado Springs, Colorado, and Pasadena, California—Stetson hats and the fictional character Sherlock Holmes had origins relating to the disease. For the latter, author and physician Arthur Conan Doyle based Sherlock Holmes’ deductive reasoning traits on the methods he used to debunk a failed tuberculosis remedy at the time.
Jeffrey Laitman, PhD, Distinguished Professor of Medical Education, talked about Leonardo da Vinci’s search for where the soul is located in the body anatomically.
Leonardo da Vinci, said Dr. Laitman, was obsessed with the human skull, and searched for the “senso commune,” which he thought was where the soul was located. The polymath thought he had found its location: at the floor of the third ventricle, just superior to the pituitary fossa.
Vasundhara Singh, MD, Associate Professor of Medicine (Hospital Medicine), and Medical Education, elaborated on the history of the medical stretcher. “Why do I care about stretchers? Because I spend half my time bent over them,” she said.
The earliest stretchers date back more than 150 years, and were also called “ambulances.” Over the decades, stretcher designs were informed by wartime constraints for space, and eventually paid more attention to comfort and materials, said Dr. Singh.
Some spiritual healing retreats in “hot igloos” in Mexico promoted on social media are simply co-opted traditional birthing huts, said Jaime Gonzalez, medical student, who talked about indigenous Mexican birthing practices.
Giving birth in hot houses is still practiced in parts of Mexico. Culture and tourism might have been intertwined, but it important for tourists to be mindful of the origins of some of these practices, said Mr. Gonzalez.
Enna Selmanovic, PhD candidate, spoke about brain donation law and representation in the United States.
Brain donation has the potential to greatly advance understanding of human disease but is complicated by law, culture, family dynamics, and ethics. “These choices shape the stories that medicine tells us about disease, and whose medical history is left out,” said Ms. Selmanovic.

Of Integrity, Persistence, Leadership, and Responsibility: Mount Sinai Graduate Students Start Their Science Training

Alec C. Kimmelman, MD, PhD, keynote speaker at Mount Sinai’s Lab Coat ceremony

Alec C. Kimmelman, MD, PhD, stepped to the podium as the keynote speaker at Mount Sinai’s Lab Coat Ceremony, the celebratory start of academic research and training for the newest PhD and MD-PhD students. He recalled how he had felt a few decades earlier when he was a Mount Sinai student. “I remember sitting in the same place,” he said, “and I was wondering what the future would hold.”

For Dr. Kimmelman, who received both his MD and PhD degrees at Mount Sinai in 2003, it would be a future of extraordinary successes—starting with his own research thesis, which set the theme for his career investigating RAS-gene-driven cancers. As a student, he would also identify and characterize a novel member of the RAS family of oncogenes, and publish three first-author papers on this topic. Today, Dr Kimmelman, one of the world’s foremost authorities on the biology of pancreatic cancers, is the newly named Dean of the NYU Grossman School of Medicine and Chief Executive Officer of NYU Langone Health.

“New tools like artificial intelligence may change the scale of discovery but they don’t change its heart,” Dr. Kimmelman told the students. “At its core, science is built on people, and the way we choose to lead each other. When I was a trainee, I didn’t think of myself as a leader in any formal sense. Leadership seems like something reserved for deans or department chairs, but I soon learned that leadership often begins in the lab.” It is where building trust and “other small acts—mentoring, collaborating, encouraging—taught me that leadership is less about hierarchy and more about responsibility,” he said.

Celebrating PhD and MD-PhD students after getting their lab coats.

“Years later, when I was asked to lead a lab, and then a cancer center and, now, a health system, the principles were the same: create an environment where curiosity can thrive, where people support one another, and where integrity is never compromised. The qualities you demonstrate every day at the bench—generosity, persistence, intellectual courage—may one day prepare you for opportunities you cannot yet imagine. Leadership is not something that you wait for a title to give you. It’s something you practice, here and now, in how you approach your science and your colleagues.”

Marta Filizola, PhD, Dean of the Graduate School of Biomedical Sciences at the Icahn School of Medicine at Mount Sinai, presided over the ceremony, which was held Thursday, September 4, at Goldwurm Auditorium.

“At Mount Sinai, we continue to advance into frontiers of research that integrate cutting-edge approaches across disciplines, from artificial intelligence and data science, to stem cell biology and regenerative medicine, all aimed at improving human health and quality of life,” she said. “Our students are at the heart of this work, bringing diverse perspectives, creativity, and a relentless drive to push the boundaries of both basic and translational research.” Dr. Filizola is also the Sharon & Frederick A. Klingenstein/Nathan G. Kase, MD Professor of Pharmacological Sciences, Professor of Neuroscience, and Professor of Artificial Intelligence and Human Health.

From left: Sarah E. Millar, PhD, Dean for Academic and Scientific Affairs, Icahn School of Medicine at Mount Sinai; Eric J. Nestler, MD, PhD; Alec C. Kimmelman, MD, PhD; and Marta Filizola, PhD, lead the students in reciting the Oath for Doctoral Students.

Eric J. Nestler, MD, PhD, Interim Dean and Nash Family Professor of Neuroscience at the Icahn School of Medicine at Mount Sinai, and Executive Vice President and Chief Scientific Officer of the Mount Sinai Health System, welcomed the students and guests and spoke about the vast advances in health care made possible by science, today’s challenges to scientific inquiry, and, significantly, the need for optimism and new discoveries.

“Advances now occurring in the laboratory and clinic, driven in part by the power of computational and molecular biology and artificial intelligence, and informed by unprecedented volumes of biomedical data,” Dr. Nestler said, “will fundamentally transform the way we understand, diagnose, treat, and prevent disease. We must shout this from the mountaintops.”

However, “We live in a time when some people do question the value of scientific inquiry,” he added. “Efforts to politicize science are most unfortunate. Today, we are seeing an unprecedented assault on the nation’s scientific enterprise.”

Still, “We must remain optimistic,” he urged. “The importance of biomedical research is too strong and too widely held for us to back away, and the biomedical research enterprise is more exciting and promising today than ever before in world history.”

 

Click on the arrows below for a slideshow of faculty and students.

How a Passion for Pharmacology and Addressing Substance Use Disorders Brought an Aspiring Researcher to Mount Sinai

Ally Parpounas, MS

Ally Parpounas, MS, is a second-year student in the MD program at the Icahn School of Medicine at Mount Sinai. She previously completed the Master of Science in Biomedical Science (MSBS) at the Graduate School of Biomedical Sciences.

It was her decision to attend the MSBS program at Mount Sinai, along with her eventual participation in a number of different programs sparked by her desire to help people in need, that would lead to medical school, which in turn has opened a number of different career pathways.

Ms. Parpounas studied neuroscience at George Washington University in Washington, D.C. and studied abroad at the Danish Institute of Study in Copenhagen, Denmark. While at the Institute, she took a psychopharmacology course that sparked her interest in research. The course taught students how neural circuitry is implicated in various psychiatric conditions. She learned how to redirect it by developing a “pharmacological cocktail” that would minimize both side effects and symptoms.

“This experience unlocked my curiosity about the physiologic mechanisms that underlie disease, and so I  began to consider a career in medicine,” she says. She soon changed her major from psychology to neuroscience.

After completing her undergraduate program in 2020, she took a gap year working at an in-patient acute care psychiatric hospital in Washington D.C. She worked there for a year before deciding that she needed more basic research experience before medical school. A Master of Science in Biomedical Science seemed like a natural next step.

While looking at master’s programs, she noticed Mount Sinai’s MSBS program. She began looking into a few labs to determine what she wanted to study and focus on. She was drawn to the pharmacology research of the Daniel Wacker, PhD lab, where she would eventually be placed. She applied to a few other programs, but the MSBS program at Mount Sinai stood out because of the strong research component. She was also interested in living in New York City because it was close to where she grew up in Peekskill, New York, about an hour north of the city. She started the MSBS program in August 2021.

During her time in the program, she worked in a number of different areas that would eventually help shape her interest in a future career in medicine.

She volunteered and conducted clinical shadowing with the Mount Sinai Human Rights Program, which provides medical and psychological evaluations for people seeking asylum in the United States. The program helps people who are typically victims of human trafficking, political violence, and other difficult circumstances. They use these evaluations and affidavits to assist with asylum cases. She worked as one of the lead clinic managers.

“The program has shown me how we can leverage our roles as clinicians to protect the health and human rights of individuals, in addition to the traditional role providing direct medical care,” she says. “It’s incredible to see the impact you make on someone life beyond just their medical care.”

She also led the graduate school’s mentorship program. Mentors help first year students navigate decisions, such as determining what they want in a lab placement. Her positive experience doing this in her first year inspired her to act as a mentor for other students during her second year.

She was also a clinic manager at the East Harlem Outreach Partnership (EHHOP), the Icahn School of Medicine’s student-run, physician-supervised, free clinic. She has continued this work while in medical school as a part of the Access to Care Team, which helps patients gain access to medicines, healthy food, and legal assistance. She  is now on ACT team leadership as the ACT Resources Chair.

She believes that the opportunities she had to get clinical experience helped shape her drive towards medical school.

“My previous experiences helped inform my direction for medical school and the type of work I want to do when I become a physician,” she says. “My training in the MSBS program helped make me a more thoughtful and intentional applicant to medical school.”

“The program has shown me how we can leverage our roles as clinicians to protect the health and human rights of individuals, in addition to the traditional role providing direct medical care. It’s incredible to see the impact you make on someone life beyond just their medical care.”

The Graduate School provides support to help master’s students seeking to continue their education through PhD or MD programs. Ms. Parpounas  worked with a student advisor in the Medical Scientist Training Program (MSTP) that helped with her medical school application process. The student advisors provide services such as creating an MCAT study schedule and essay review and revision help. This support was available as needed, but it was up to Ally to schedule meetings and manage the process.

“When I was studying for the MCAT exam, my friends in the medical school and the MSAP advisors (the MSTP student advisors) recommended study plans and resources, like Anki flashcards, that were more similar to what people use in medical school vs undergrad. I think studying in this way helped me get an MCAT score that I was proud of and made me feel more ready for the academic rigor of medical school,” she says.

She completed the MSBS program in June 2023 and received the Award for Excellence in Biomedical Science Leadership and Service Award for her volunteering and mentorship. She then applied to a few MD programs and was accepted to the program at the Icahn School of Medicine. Ally appreciates being in the first class to experience the new ASCEND curriculum, which was introduced in the fall of 2024. The objective of this curriculum revamp is to provide a personalized and active-learning approach aimed at transforming the way knowledge and clinical experiences are acquired.

Upon completing her MD, Ally is interested in a few different paths in medicine. She is currently working with Leah Habersham, MD, Director of the Bridge Program at Mount Sinai. The Bridge Program is an integrated clinic providing women’s health care, including obstetrics and gynecology, along with care for substance use disorder.

These experiences at Mount Sinai have sparked an interest in a wide variety of areas, including specialties such as obstetrics and gynecology, pediatrics, and internal medicine. But she believes it’s important to keep an open mind and will explore more once she begins her clinical clerkships in February 2026.

After Sharpening His Engineering Skills in Industry, Karan Lingineni Gets a Master of Science in Clinical Research (MSCR), Building on a Passion for Research-Driven Approaches to Clinical Care

After earning dual degrees in Computer Science and Neurobiology from the University of California, Berkeley, in 2022, Karan Lingineni  moved to Seattle and worked at Amazon’s Alexa AI division, then later at Kyndryl (formerly IBM Cloud Consulting), where he served as a Cloud Architect while completing his graduate studies at Mount Sinai.

In the following Q&A, Mr. Lingineni reveals how he merged his interests in technology, computer science, and precision medicine to launch a most unique academic and career path.

What is your background?

My career has centered on the intersection of Artificial Intelligence/Machine Learning (AI/ML) and cloud infrastructure with medical research, spanning domains such as oncology, cardiology, and behavioral neuroscience. I’ve previously held positions at NVIDIA and Roche Pharmaceuticals, where I contributed to non-small cell lung cancer tumor classification pipelines and time-series anomaly detection for medical IoT (Internet of Things) devices.

What first attracted you to this field?

In high school, I discovered a deep passion for technology and computer science, but I often encountered advice to “pick one.” Even then, I believed computer science could become a powerful tool to transform patient care.

It wasn’t until  internships at NVIDIA, Roche, and Dell Technologies that I saw how fields such as bioinformatics, predictive analytics, and precision medicine were already reshaping health care. These experiences helped me visualize a career where I could integrate both disciplines meaningfully. After spending time in industry sharpening my engineering skills, I sought a program that could help me develop research fluency while staying true to my interdisciplinary background—and Mount Sinai was the perfect fit.

Who were your mentors and what are some of your research highlights?

I started two research collaborations: with Michelle Mendiolaza, a student who received her PhD in May and was in the Laurie Keefer, PhD, lab, focusing on inflammatory bowel disease (IBD) and resilience, and Muhammad Parvaz, PhD, at the Motivational and Affective Psychopathology (MAP) Lab, which investigates cognitive-affective processes in substance use disorders.With Dr. Mendiolaza’s mentorship, I assisted in the development and validation of a disease-specific resilience measure for IBD patients—RISE-IBD—which we recently published in BMC Gastroenterology. At the MAP Lab, under the guidance of Dr. Parvaz and Riaz Shaik, MBBS, PhD, I was able to merge my technical background with research in addiction neuroscience. My thesis project explored the development of a generative AI-powered companion platform designed to support craving regulation in patients with cocaine-use disorder—a novel approach integrating cognitive-behavioral therapy with real-time ecological momentary assessment (ProQuest).

Why Mount Sinai—what, specifically, are the strong points of the program?

As someone with a nontraditional background, I was looking for a program that would challenge me academically while embracing my interdisciplinary identity. Mount Sinai stands out not just for its leadership in AI and translational medicine, but for its breadth across health policy, entrepreneurship, and bioethics.

The curriculum is incredibly well-rounded. Dr. Ostertag’s [Gary Ostertag, PhD] bioethics seminar is essential for understanding the evolving societal responsibilities of modern medicine. Dr. Sacks [Henry Sacks, MD, PhD] and Dr. Gabrilove’s [Janice L. Gabrilove, MD] clinical research methods course offers an excellent foundation for designing impactful studies. Dr. Doucette’s [John Doucette, PhD] biostatistics lectures are rigorous yet approachable, and Dr. Swan’s [Judith Swan, PhD] workshops in scientific writing and grant strategy helped elevate the quality and clarity of my own proposals. I also appreciated how accessible opportunities were—from joining labs to getting involved in new initiatives—and  I always felt supported in exploring ideas and connecting with mentors.

Also, how did you excel at Mount Sinai?

I pursued my passion for innovation and entrepreneurship through the THRIVE Fellowship, (Mount Sinai’s Targeted Healthcare Innovation Fellowship). This program provided a unique platform to collaborate with interdisciplinary teams, combining clinical insights with technological solutions to address pressing health care challenges. During the fellowship, I co-founded EveHealth.AI with MD student Ryan Afreen and PhD student Nancy Zhang, an initiative aimed at enhancing the diagnosis of Polycystic Ovary Syndrome (PCOS) using AI-driven digital biomarkers. Our team developed a prototype that leverages patient health data to improve early detection and diagnosis of PCOS. Our efforts were recognized when EveHealth.AI was selected as a winner at the Mount Sinai Innovation Awards, highlighting the potential impact of our solution in women’s health.

These opportunities allowed me to apply my interdisciplinary background in computer science and medicine to real-world problems, fostering a deeper understanding of the innovation process from concept to potential commercialization. This experience honed my skills in health care technology development and reinforced my commitment to leveraging technology for improved patient outcomes.

What’s Next?

This fall, I’ll be attending UT Southwestern in Dallas as a medical student. I plan to continue collaborating with Dr. Parvaz and the MAP Lab remotely while I explore career paths in either cardiology or psychiatry. No matter the specialty, I’m committed to bringing an engineering mindset and research-driven approach to clinical care.

Pin It on Pinterest